Apyx Medical Inc (APYX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Charles D. Goodwin
Employees:
270
5115 ULMERTON ROAD, CLEARWATER, FL 33760
800-537-2790

Apyx Medical Corporation offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation.

Data derived from most recent annual or quarterly report
Market Cap 124.206 Million Shares Outstanding34.598 Million Avg 30-day Volume 334.412 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.12
Price to Revenue3.1883 Debt to Equity0.0 EBITDA-18.038 Million
Price to Book Value3.6996 Operating Margin-39.6548 Enterprise Value140.738 Million
Current Ratio4.137 EPS Growth-0.333 Quick Ratio2.139
1 Yr BETA 1.0866 52-week High/Low 11.19 / 1.31 Profit Margin-39.4536
Operating Cash Flow Growth-33.0137 Altman Z-Score6.9019 Free Cash Flow to Firm -17.147 Million
Earnings Report2023-03-16
View SEC Filings from APYX instead.

View recent insider trading info

Funds Holding APYX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APYX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CITRONOWICZ MOSHE SR. V.P. OF OPERATIONS

  • Officer
72,000 2023-01-11 1

GOODWIN CHARLES D. II CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
243,000 2023-01-11 1

SEMB TARA CHIEF FINANCIAL OFFICER

  • Officer
96,000 2023-01-11 1

HORNSBY TODD EXECUTIVE VICE PRESIDENT

  • Officer
100,000 2023-01-11 1

WALDMAN LAWRENCE

  • Director
13,563 2022-05-19 1

GERAGHTY MICHAEL

  • Director
13,500 2022-05-11 1

SWANDAL CRAIG A.

  • Director
0 2022-03-21 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GOODWIN CHARLES D. II - Director - Officer CHIEF EXECUTIVE OFFICER

2023-01-13 16:16:05 -0500 2023-01-11 A 243,000 a 243,000 direct

SEMB TARA - Officer CHIEF FINANCIAL OFFICER

2023-01-13 16:16:48 -0500 2023-01-11 A 96,000 a 96,000 direct

CITRONOWICZ MOSHE - Officer SR. V.P. OF OPERATIONS

2023-01-13 16:17:33 -0500 2023-01-11 A 72,000 a 72,000 direct

HORNSBY TODD - Officer EXECUTIVE VICE PRESIDENT

2023-01-13 16:18:15 -0500 2023-01-11 A 100,000 a 100,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
APYX MEDICAL CORP APYX 2023-02-03 22:15:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 21:45:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 21:15:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 20:45:06 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 20:15:04 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 19:45:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 19:15:04 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 18:45:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 18:15:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 17:45:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 17:15:04 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 16:45:04 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 16:15:03 UTC 4.1017 0.4683 200000
APYX MEDICAL CORP APYX 2023-02-03 15:45:03 UTC 4.0981 0.4719 200000
APYX MEDICAL CORP APYX 2023-02-03 15:15:03 UTC 4.0981 0.4719 200000
APYX MEDICAL CORP APYX 2023-02-03 14:45:04 UTC 3.8481 0.4719 200000
APYX MEDICAL CORP APYX 2023-02-03 14:15:04 UTC 3.8481 0.4719 200000
APYX MEDICAL CORP APYX 2023-02-03 13:45:03 UTC 3.8481 0.4719 200000
APYX MEDICAL CORP APYX 2023-02-03 13:15:03 UTC 3.8481 0.4719 200000
APYX MEDICAL CORP APYX 2023-02-03 12:45:03 UTC 3.8481 0.4719 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund APYX -3700.0 shares, $-16613.0 2022-09-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments